Patrick J. Christmas Receives Stock Award at Regenxbio Inc (RGNX) — SEC Form 4, Jan 06, 2021
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
16.4K sh
2,572 → 16,372
Equity Change
+536.6%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Patrick J. Christmas CIK 0001521123 |
GC
|
Patrick J. Christmas at Regenxbio Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Regenxbio Inc
| 2026-11-03 | Award | — | View |
| 2026-08-04 | - | — | View |
| 2026-02-03 | - | — | View |
| 2026-01-08 | Award | — | View |
| 2026-01-06 | - | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2021-01-04 | A - Award/Grant | 13,800 A | $0.00 | — | 16,372 | Direct |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $44.97 | 2021-01-04 | A - Award/Grant | 62,500 A | $0.00 | 2031-01-04 | 62,500 Common Stock | Direct |
Footnotes (2)
- F1
- Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer. Show more
- F2
- 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer. Show more
Related filings at Regenxbio Inc
Institutional Holders
13F holders · Jun 30, 2026
166
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $76.6M
- Redmile Group, Llc $52.3M
- State Street Corporation $35.6M
5%+ Holders · 13D/G
4 filers
-
Jp Morgan Chase & Co 5.3%
-
Redmile Group, Llc 9.9%
-
Black Rock, Inc. 7.3%
Other insiders at Regenxbio Inc
GET /v1/forms/4/0001562180-21-000140
API docs
View Original SEC Filing